---
input_text: D-penicillamine and plasmapheresis in acute liver failure secondary to
  Wilson's disease. We report a case of a 19-year-old woman with acute liver failure,
  Coombs negative hemolytic anemia, and renal failure as initial manifestations of
  Wilson disease with recovery following medical treatment. The clinical picture and
  low serum transaminase and alkaline phosphatase levels gave us a clue to suspect
  Wilson disease and to initiate plasmapheresis and D-penicillamine soon after admission.
  The serum and urinary copper levels were elevated with low serum ceruloplasmin.
  We proceeded to ambulatory follow-up with medical treatment with D-penicillamine.
  A few months later, during the course of a laparoscopic cholecystectomy because
  of symptomatic gallstone disease, a liver biopsy sample was obtained that showed
  histological liver fibrosis and strongly elevated levels of liver tissue copper.
raw_completion_output: |-
  primary_disease: Wilson's disease

  medical_actions: plasmapheresis; D-penicillamine administration; laparoscopic cholecystectomy; liver biopsy

  symptoms: acute liver failure; Coombs negative hemolytic anemia; renal failure; low serum transaminase levels; low alkaline phosphatase levels; elevated serum and urinary copper levels; low serum ceruloplasmin; histological liver fibrosis

  chemicals: D-penicillamine; copper

  action_annotation_relationships: plasmapheresis TREATS acute liver failure IN Wilson's disease; D-penicillamine administration TREATS acute liver failure IN Wilson's disease; D-penicillamine administration TREATS high copper levels (with copper) IN Wilson's disease; laparoscopic cholecystectomy TREATS symptomatic gallstone disease IN Wilson's disease; liver biopsy PREVENTS misdiagnosis IN Wilson's disease
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  liver biopsy PREVENTS misdiagnosis IN Wilson's disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - plasmapheresis
    - D-penicillamine administration
    - laparoscopic cholecystectomy
    - MAXO:0000376
  symptoms:
    - HP:0006554
    - Coombs negative hemolytic anemia
    - HP:0000083
    - low serum transaminase levels
    - low alkaline phosphatase levels
    - elevated serum and urinary copper levels
    - low serum ceruloplasmin
    - histological liver fibrosis
  chemicals:
    - CHEBI:7959
    - CHEBI:28694
  action_annotation_relationships:
    - subject: plasmapheresis
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: administration
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
      subject_extension: CHEBI:7959
    - subject: administration
      predicate: TREATS
      object: high copper levels
      qualifier: MONDO:0010200
      object_qualifier: with copper
      subject_extension: CHEBI:7959
      object_extension: with copper
    - subject: laparoscopic cholecystectomy
      predicate: TREATS
      object: symptomatic gallstone disease
      qualifier: MONDO:0010200
    - subject: MAXO:0000376
      predicate: PREVENTS
      object: misdiagnosis
      qualifier: MONDO:0010200
named_entities:
  - id: MONDO:0010200
    label: Wilson disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000004
    label: surgery (laparotomy, rectal mobilization, rectopexy, the partial sigmoid
      colon resection with the primary anastomosis)
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: HP:0006554
    label: acute liver failure
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0009095
    label: Zinc therapy
  - id: HP:0002344
    label: Neurologic deterioration
  - id: MAXO:0001298
    label: therapy
  - id: HP:0001392
    label: liver disease
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0009044
    label: Crigler-Najjar syndrome
  - id: MAXO:0000376
    label: liver biopsy
  - id: MAXO:0000127
    label: genetic testing
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:28694
    label: copper
  - id: HP:0001399
    label: hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: end-stage liver disease
  - id: HP:0100626
    label: end-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0004787
    label: fulminant hepatitis
  - id: HP:0031811
    label: bilirubinuria
  - id: HP:0001397
    label: hepatic steatosis
  - id: CHEBI:16359
    label: cholic acid
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001337
    label: tremor
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000603
    label: peritoneal dialysis
  - id: CHEBI:7959
    label: D-penicillamine
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: imbalance
  - id: HP:0000093
    label: proteinuria
  - id: HP:0032199
    label: abnormal prothrombin time
  - id: MAXO:0000167
    label: Antiepileptic therapy
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:9168
    label: Rapamycin
  - id: CHEBI:55379
    label: Cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: CHEBI:4031
    label: Cyclosporine
  - id: HP:0000083
    label: renal failure
